The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis

2010/04/10 by Lisette G. Capelle, Annemarie C. de Vries, Jelle Haringsma +9 · 27 citations
Medicine · #Helicobacter pylori-related gastroenterology studies #Gastric Cancer Management and Outcomes #Microscopic Colitis

paper · doi:10.1016/j.gie.2009.12.029

Citations

• The Measurement of Observer Agreement for Categorical Data

Cited by

• Towards deep-learning based detection and quantification of intestinal metaplasia on digitized gastric biopsies: a multi-expert comparative study
• The OLGIMA system for gastric cancer risk assessment. A useful method based on the histological Sydney consensus
• Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). [europepmc]
• Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. [europepmc]
• Management of gastric polyps: an endoscopy-based approach. [europepmc]
• Diagnosis and management of high risk group for gastric cancer. [europepmc]
• Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. [europepmc]
• Kyoto global consensus report on Helicobacter pylori gastritis. [europepmc]
• The stomach in health and disease. [europepmc]
• Gastric Cancer: How Can We Reduce the Incidence of this Disease? [europepmc]
• Current Perspectives on Gastric Cancer. [europepmc]
• Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale. [europepmc]
• Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. [europepmc]
• British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. [europepmc]
• AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. [europepmc]
• AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. [europepmc]
• AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. [europepmc]
• Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. [europepmc]
• Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions. [europepmc]
• Changes of the Gastric Mucosal Microbiome Associated With Histological Stages of Gastric Carcinogenesis. [europepmc]
• Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. [europepmc]
• The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions. [europepmc]
• Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP). [europepmc]
• AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. [europepmc]
• Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. [europepmc]
• Controlling Gastric Cancer in a World of Heterogeneous Risk. [europepmc]
• Helicobacter pylori infection. [europepmc]